MA
Marinomed Biotech AG
MARI.VI · VIE
4.24 € -5.78% (-0.26 €)
1M -16.67%
Market Cap 17.4M €
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
78 /100
Cheap P/S 1.89x
EV/FFO N/A
P/E N/A
Growth
41 /100
Stable Rev. growth 4.17%
Book val. growth N/A
EPS growth N/A
Profitability
2 /100
Weak Op. margin 55.85%
Gross margin 12.45%
FCF margin 50.71%
Quality
11 /100
Poor Asset turnover 0.63x
ROIC 43.07%
ROA 46.50%
Debt
54 /100
Moderate Net debt/EBITDA -5.30x
Current ratio 0.74x
Int. coverage -3.11x
Stability
51 /100
Moderate EPS volatility 5.06%
Beta -0.23x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MARI.VI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Andreas Grassauer
Employees
32
Headquarters
Korneuburg
Upcoming events
16 SEP
Earnings
Upcoming earnings report